Institutional investors purchased a net $390.2 thousand shares of ENZ during the quarter ended July 2016, and now own 62.21% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GLOBEFLEX CAPITAL LP Bought 225.8 Thousand shares of Enzo Biochem Inc